PI4K2A promotes cancer cell motility by regulating c-MET recycling

Abstract Non-small cell lung cancer (NSCLC) remains the leading cause of cancer mortality, largely due to metastatic disease. Cell surface proteins regulate tumor–stroma interactions and metastatic progression, and their abundance is dynamically controlled by secretion and endocytic recycling pathways. Using cancer cell surfaceome profiling, we identified phosphatidylinositol 4-kinase type 2α (PI4K2A) as a key regulator of cell surface protein levels. PI4K2A controls the membrane abundance and activity of receptor tyrosine kinases, including the c-MET proto-oncogene (MET), thereby promoting cancer cell motility - an early step in metastasis. Mechanistically, PI4K2A interacts with MET and directs endocytosed MET to RAB14-positive recycling endosomes, enhancing MET recycling and activation. Notably, this pro-recycling and pro-migratory function is independent of PI4K2A kinase activity and instead depends on its interaction with MET and RAB14 endosomes. These findings reveal a kinase-independent role for PI4K2A in regulating the cancer cell surfaceome.

Authors

Institutions

Publication Details

Journal
EMBO Reports
Published
2026-11-11
DOI
https://doi.org/10.1038/s44319-026-00993-0
Primary Topic
Cellular transport and secretion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PI4K2A promotes cancer cell motility by regulating c-MET recycling

William K. Russell, Xuejun Zhang, Shike Wang, Guan-Yu Xiao et al.
EMBO Reports
Cellular transport and secretion
article

PI4K2A promotes cancer cell motility by regulating c-MET recycling

William K. Russell, Xuejun Zhang, Shike Wang, Guan-Yu Xiao, Oluwafunminiyi E. Obaleye, Kevin L. Fulp, Xiaochao Tan, Sieun Lee, Zide Chen, Kenneth Marquez
article en

Abstract

Abstract Non-small cell lung cancer (NSCLC) remains the leading cause of cancer mortality, largely due to metastatic disease. Cell surface proteins regulate tumor–stroma interactions and metastatic progression, and their abundance is dynamically controlled by secretion and endocytic recycling pathways. Using cancer cell surfaceome profiling, we identified phosphatidylinositol 4-kinase type 2α (PI4K2A) as a key regulator of cell surface protein levels. PI4K2A controls the membrane abundance and activity of receptor tyrosine kinases, including the c-MET proto-oncogene (MET), thereby promoting cancer cell motility - an early step in metastasis. Mechanistically, PI4K2A interacts with MET and directs endocytosed MET to RAB14-positive recycling endosomes, enhancing MET recycling and activation. Notably, this pro-recycling and pro-migratory function is independent of PI4K2A kinase activity and instead depends on its interaction with MET and RAB14 endosomes. These findings reveal a kinase-independent role for PI4K2A in regulating the cancer cell surfaceome.

EMBO Reports
University of Kentucky (US), The University of Texas Medical Branch at Galveston (US), The University of Texas Health Science Center at Houston (US)
Cellular transport and secretion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon